Douglas Doerfler net worth and biography

Douglas Doerfler Biography and Net Worth

Founder of MaxCyte

Mr. Doerfler founded MaxCyte in 1999 as one of three cofounders who started MaxCyte to commercialize flow electroporation technology and served as the company’s President and Chief Executive Officer through 2023. He has more than 35 years of experience in biotechnology product and company development, commercialization and international financing. Previously, Mr. Doerfler was President, Chief Executive Officer and Director of Immunicon Corporation and also held various executive leadership positions with Life Technologies (now Thermo Fisher Scientific). He is an active life sciences industry advocate, serving as Chair Emeritus on the Tech Council of Maryland and member of the executive committee for the Biotechnology Innovation Organization (BIO).

What is Douglas Doerfler's net worth?: The estimated net worth of Douglas Doerfler is at least $526.45 thousand as of December 1st, 2023. Mr. Doerfler owns 333,197 shares of MaxCyte stock worth more than $526,451 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Doerfler may own. Additionally, Mr. Doerfler receives an annual salary of $2,340,000.00 as Founder at MaxCyte. Learn More about Douglas Doerfler's net worth.
How old is Douglas Doerfler?: Mr. Doerfler is currently 68 years old. There are 6 older executives and no younger executives at MaxCyte. Learn More on Douglas Doerfler's age.
What is Douglas Doerfler's salary?: As the Founder of MaxCyte, Inc., Mr. Doerfler earns $2,340,000.00 per year. Learn More on Douglas Doerfler's salary.
How do I contact Douglas Doerfler?: The corporate mailing address for Mr. Doerfler and other MaxCyte executives is 22 FIRSTFIELD ROAD SUITE 110, GAITHERSBURG MD, 20878. MaxCyte can also be reached via phone at 301-944-1700 and via email at [email protected]. Learn More on Douglas Doerfler's contact information.
Has Douglas Doerfler been buying or selling shares of MaxCyte?: Douglas Doerfler has not been actively trading shares of MaxCyte within the last three months. Most recently, Douglas Doerfler sold 20,200 shares of the business's stock in a transaction on Friday, December 1st. The shares were sold at an average price of $5.00, for a transaction totalling $101,000.00. Following the completion of the sale, the chief executive officer now directly owns 333,197 shares of the company's stock, valued at $1,665,985. Learn More on Douglas Doerfler's trading history.
Who are MaxCyte's active insiders?: MaxCyte's insider roster includes Douglas Doerfler (Founder), Douglas Doerfler (Founder), Stanley Erck (Director), John Johnston (Director), Maher Masoud (CEO), David Sandoval (Senior Vice President and General Counsel), Ali Soleymannezhad (Insider), and Douglas Swirsky (CFO). Learn More on MaxCyte's active insiders.
Are insiders buying or selling shares of MaxCyte?: In the last year, MaxCyte insiders bought shares 5 times. They purchased a total of 355,000 shares worth more than $479,950.00. In the last year, insiders at the sold shares 7 times. They sold a total of 29,653 shares worth more than $95,594.74. The most recent insider tranaction occured on August, 13th when CFO Douglas J Swirsky bought 50,000 shares worth more than $64,500.00. Insiders at MaxCyte own 3.3% of the company. Learn More about insider trades at MaxCyte.
Information on this page was last updated on 8/13/2025.

Douglas Doerfler Insider Trading History at MaxCyte

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2023	Sell	20,200	$5.00	$101,000.00	333,197
11/29/2023	Sell	5,350	$5.00	$26,750.00	333,197
7/12/2023	Sell	16,757	$5.02	$84,120.14	333,197
7/10/2023	Sell	445	$5.01	$2,229.45	333,197
6/13/2023	Sell	14,968	$5.03	$75,289.04	333,197
5/3/2023	Sell	16,149	$5.02	$81,067.98	333,197
4/11/2023	Sell	2,182	$5.00	$10,910.00	333,197
4/6/2023	Sell	27,862	$5.03	$140,145.86	333,197
4/4/2023	Sell	7,470	$5.03	$37,574.10	333,197
1/5/2023	Sell	10,234	$5.04	$51,579.36	333,197
1/3/2023	Sell	10,613	$5.13	$54,444.69	333,197

Douglas Doerfler Buying and Selling Activity at MaxCyte

MaxCyte Company Overview

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Today's Range

Now: $1.58

$1.50

$1.62

50 Day Range

MA: $1.62

$1.44

$1.83

2 Week Range

Now: $1.58

$1.26

$5.20

Volume

577,871 shs

Average Volume

856,912 shs

Market Capitalization

$168.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Douglas Doerfler Biography and Net Worth

What is Douglas Doerfler's net worth?

How old is Douglas Doerfler?

What is Douglas Doerfler's salary?

How do I contact Douglas Doerfler?

Has Douglas Doerfler been buying or selling shares of MaxCyte?

Who are MaxCyte's active insiders?

Are insiders buying or selling shares of MaxCyte?